Please try another search
Nightstar Therapeutics plc, a clinical-stage gene therapy company, engages in licensing of IP and research and development in the field of biotechnology in the United Kingdom. It focuses on adeno-associated virus treatments for inherited retinal deficits. The company was incorporated in 2017 and is headquartered in Maidenhead, United Kingdom. As of June 7, 2019, Nightstar Therapeutics Limited operates as a subsidiary of Tungsten Bidco Limited.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review